User profiles for Senlin Xu
Senlin XuZhejiang University Verified email at zju.edu.cn Cited by 369 |
Pharmacological profiling of a berbamine derivative for lymphoma treatment
Ca 2+ /calmodulin-dependent protein kinase II γ (CAMKIIγ) has been identified as a potential
target for treating cancer. Based on our previous study of berbamine (BBM) as a CAMKIIγ …
target for treating cancer. Based on our previous study of berbamine (BBM) as a CAMKIIγ …
SOSTDC1-producing follicular helper T cells promote regulatory follicular T cell differentiation
Germinal center (GC) responses potentiate the generation of follicular regulatory T (T FR )
cells. However, the molecular cues driving T FR cell formation remain unknown. Here, we …
cells. However, the molecular cues driving T FR cell formation remain unknown. Here, we …
Alternative approaches to target Myc for cancer treatment
The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL,
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc, respectively. …
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc, respectively. …
[HTML][HTML] Bile acid–mediated activation of brown fat protects from alcohol-induced steatosis and liver injury in mice
Background & Aims Alcohol-associated liver disease (AALD) is one of the most common
causes of liver injury and failure. Limited knowledge of the mechanisms underlying AALD …
causes of liver injury and failure. Limited knowledge of the mechanisms underlying AALD …
Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
…, T Chen, R Huang, J Wu, Q Zhao, Q Wu, S Xu… - Nature, 2019 - nature.com
T cells become dysfunctional when they encounter self antigens or are exposed to chronic
infection or to the tumour microenvironment 1 . The function of T cells is tightly regulated by a …
infection or to the tumour microenvironment 1 . The function of T cells is tightly regulated by a …
[PDF][PDF] Nanog regulates self‐renewal of cancer stem cells through the insulin‐like growth factor pathway in human hepatocellular carcinoma
J Shan, J Shen, L Liu, F Xia, C Xu, G Duan, Y Xu… - …, 2012 - Wiley Online Library
Hepatocellular carcinoma (HCC) exhibits cellular heterogeneity and embryonic stem‐cell–related
genes are preferentially overexpressed in a fraction of cancer cells of poorly …
genes are preferentially overexpressed in a fraction of cancer cells of poorly …
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma
…, Z Yan, W Xu, H Lu, Q Li, M Liang, Y Jia, C Chen, S Xu… - Cancer cell, 2023 - cell.com
Malignant gliomas are largely refractory to immune checkpoint blockade (ICB) therapy. To
explore the underlying immune regulators, we examine the microenvironment in glioma and …
explore the underlying immune regulators, we examine the microenvironment in glioma and …
Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells
Cyclin-dependent kinase 2 (CDK2) complex is significantly over-activated in many cancers.
While it makes CDK2 an attractive target for cancer therapy, most inhibitors against CDK2 …
While it makes CDK2 an attractive target for cancer therapy, most inhibitors against CDK2 …
Glucocorticoid nanoformulations relieve chronic pelvic pain syndrome and may alleviate depression in mice
Y Yang, R Hu, J Zheng, Q Wang, S Xu, Z Zhou… - Journal of …, 2023 - Springer
Background Chronic pelvic pain syndrome (CPPS) is a typical symptom of chronic prostatitis
(CP) in males that may cause abnormal urination, sexual dysfunction, or depression and …
(CP) in males that may cause abnormal urination, sexual dysfunction, or depression and …
[HTML][HTML] Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1
…, Y Liu, X Yao, Y Ping, T Jiang, Q Liu, S Xu… - The American journal of …, 2011 - Elsevier
Highly malignant human gliomas overexpress the G-protein–coupled chemoattractant receptor
formyl peptide receptor (FPR1), which promotes tumor progression when activated. Our …
formyl peptide receptor (FPR1), which promotes tumor progression when activated. Our …